Clinical trial
Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine Compared to Icodextrin Alone, an Exploratory Study.
NCT04086212 is registered in ClinicalTrials.gov with Iperboreal Pharma Srl as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine Compared to Icodextrin Alone, an Exploratory Study.
- Lead sponsor
- Iperboreal Pharma Srl
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- October 2, 2019
- Completion date
- April 30, 2023
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease (esrd)